Is surgical intervention frequently required for medically managed macroprolactinomas? A study of spontaneous

Patricia de Lacy1, Silas Benjamin, Rebecca Dixon

  • 1Department of Neurosurgery, Morriston Hospital, Swansea, UK. pdelacy44@hotmail.com

Surgical Neurology
|August 12, 2009
PubMed
Abstract

Insights

Spontaneous CSF rhinorrhea is a significant risk in macroprolactinoma patients, especially with sphenoid sinus invasion. Medical therapy can precipitate this complication, necessitating neurosurgical intervention.

Area of Science:

  • Neuroendocrinology
  • Neurosurgery
  • Oncology

Background:

  • Spontaneous cerebrospinal fluid (CSF) rhinorrhea is infrequently documented in macroprolactinoma patients.
  • Previous understanding suggested this complication was exceedingly rare.

Purpose of the Study:

  • To investigate the incidence and risk factors of spontaneous CSF rhinorrhea in macroprolactinoma patients.
  • To evaluate adverse effects associated with medical therapy for macroprolactinomas.

Main Methods:

  • Retrospective analysis of 30 patients with macroprolactinomas (>1.0 cm) from the Swansea neuroendocrine database.
  • Review of patient data including serum prolactin levels, tumor invasion extent, and treatment outcomes.

Main Results:

  • Four patients developed CSF rhinorrhea requiring surgery after initiating medical therapy.
  • All four patients with CSF rhinorrhea had tumors invading both the cavernous and sphenoid sinuses and high initial prolactin levels (>75,000 mU/L).
  • Other serious adverse events included acute psychosis and a sexual offense in one patient each.

Conclusions:

  • Serious adverse effects are not rare in medically treated macroprolactinoma patients.
  • Macroprolactinomas invading the sphenoid sinus pose a high risk for developing CSF rhinorrhea.
  • CSF rhinorrhea in these patients often necessitates neurosurgical intervention.

Related Concept Videos